Widgets Magazine

Tweets by @Stanford_Daily

BOSP relaxes foreign language requirements for many programs. https://t.co/H1l6VNzyyg: 7 hours ago, The Stanford Daily
Death of Ph.D. student in India sparks conversation on caste. https://t.co/AO40qmjyfx: 9 hours ago, The Stanford Daily
Ge Wang talks Laptop Orchestra, music startup. https://t.co/5QDRF3aCkk: 10 hours ago, The Stanford Daily
Taking down concussions: https://t.co/myFmbG7DVq: 12 hours ago, The Stanford Daily
Stanford Daily headlines: 3/10/2016 - https://t.co/DIWO9v78os: 16 hours ago, The Stanford Daily
Stanford Daily headlines: 3/9/2016 - https://t.co/YB2dtrfouo: 2 days ago, The Stanford Daily
Stanford Daily headlines: 3/8/2016 - https://t.co/jvfGEdl01m: 3 days ago, The Stanford Daily
Stanford Daily headlines: 3/7/2016 - https://t.co/3kcdrHt71d: 4 days ago, The Stanford Daily
Stanford Daily headlines: 3/4/2016 - https://t.co/3R9amXGpGO: 7 days ago, The Stanford Daily
Grad students might see increase in fees, according to proposal. https://t.co/nl9Dg72Ybm: 1 week ago, The Stanford Daily

Stanford Medicine appoints new chair of pathology

Christina Pan

By: Christina Pan

Thomas Montine, current chair of pathology at the University of Washington, was recently appointed as the new chair of the Stanford University School of Medicine’s Department of Pathology. According to Stanford Medicine’s News Center, Montine’s term starts on May 1.

According to Paul Khavar, Chair of Dermatology and co-leader of the search committee for the new chair of pathology, Montine’s leadership within the realm of neuropathology, especially in genomics, complements Stanford Medicine’s goal of providing better patient care.

Montine’s own research in neuropathology examines the link between cognitive impairment and structural and molecular abnormalities, as well as how these abnormalities in turn can cause Alzheimer’s and Parkinson’s disease. Montine has also put particular emphasis on precision health, including genomics, early detection and personalized therapies. He directs the Alzheimer’s Disease Research Center and Pacific Northwest Udall Center, which are national research centers on Alzheimer’s and Parkinson’s disease.  

Many within Stanford’s medical realm are enthusiastic about Montine’s appointment and future contributions.

“Many individuals at Stanford Health Care and Lucile Packard Children’s Hospital Stanford working to advance clinical genomics are very excited about Dr. Montine’s interest and contributions in this area [of genomics],” said Professor of Pediatrics Louanne Hudgins, co-leader of the search committee for a pathology chair.

Khavar echoed this sentiment, adding that Montine’s “scientific strengths, program leadership and clinical expertise” will help lead Stanford’s pathology department to a brighter future.

 

 

Contact Christina Pan at capan ‘at’ stanford.edu.

Tagged with:

  • MarkC

    It is wonderful to have Thomas Montine join Stanford and hope he can put renewed focus on the pathology for M.E., Myalgic Encephalomyelitis, (aka CFS, chronic fatigue Syndrome) that affects 2 million in USA including a number of Stanford students, Alumni, and families and others in the greater Palo Alto and Stanford area. Stanford needs to find biomarkers and underlying genetic, biochemistry for this “Forgotten Plague”. Hope he can draw NIH and CDC or philanthropic funding to cure M.E, since it is one of the most grossly underfunded diseases, due to decades of discrimination against M.E. by the NIH and CDC. To gain awareness about this major disease with minor funding, see http://www.stanforddaily.com/2016/01/05/tackling-chronic-fatigue-syndrome/ or End-MECFS.org. Some of the best R&D on the planet is happening this year with Stanford Genetics Professor Ron Davis together with OpenMedicineFoundation.org, but much more funding is needed to help Stanford lead the cure for 20,000,000 afflicted worldwide incl approx 1000 Stanford Alumni or their families.

  • MarkC

    Myalgic Encephalomyelitis is not rare and I know of current undergrads, graduates, alumni with this disease. At least one MIT undergrad then Stanford graduate who was a successful engineer with Apple with patents, died too early from this disease, as documented in Stanford Magazine Jan 2001:

    Anitta L. Bliss, MS ’87, of San Jose, January 18, at 40, of chronic fatigue immune syndrome. She earned her bachelor’s degree in mechanical engineering from MIT. After receiving her master’s from Stanford, she worked in Apple Computer’s portables division until 1995, when illness forced her to leave. Survivors include her fiancé, Justin Milliun.

    Despite the importance of this disease, Stanford medicine one Clinician only, Dr. Jose Montoya with focus on this disease so with waiting list that can be years for a serious illness. Hope Thomas Morine and Stanford can increase staffing, funding and R&D to cure M.E. and stop letting millions spend life imprisoned in their rooms with little chance for parole back into the real world, despite doing nothing wrong. This is a great challenge for medicine, and could deserve a Nobel prize if solved.

© 2016 THE STANFORD DAILY